Berger Dietmar bought GILD
January 2, 2025 · Form 4 insider transaction
Berger Dietmar bought 48,975 shares of Gilead Sciences, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
48,975
Price
N/A
Total value
N/A
InsiderBerger Dietmar
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2025
Filing dateJanuary 3, 2025
Shares owned after48,975
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.; The restricted stock units have a three year vesting schedule. 33.33% will vest on the anniversary of the date of grant until fully vested.